Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - fentanylcitrat - resoribletter, sublinguale - 200 mikrogram

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 300 mikrogram

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 400 mikrogram

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - fentanylcitrat - resoribletter, sublinguale - 400 mikrogram

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 600 mikrogram

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

kyowa kirin holdings b.v. - fentanylcitrat - resoribletter, sublinguale - 800 mikrogram